{{Rsnum
|rsid=16844489
|Chromosome=3
|position=137093276
|Orientation=plus
|GMAF=0.06198
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 10.8 | 89.2
| HCB | 0.0 | 24.4 | 75.6
| JPT | 2.2 | 33.3 | 64.4
| YRI | 0.0 | 7.9 | 92.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 24.4 | 75.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs16844489
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084216
|Annotation=In a multi-stage case-control study of Type I Diabetes Mellitus patients from Finland, Iceland and the British Isles, this SNP(rs16844489) was part of a haplotype associated with risk of Diabetic Nephropathy . The other tag SNPs for the haplotype are rs17374749,rs1866813 and rs6766709.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus, Type 1; Diabetic Nephropathies
|Curation Level=Curated
|PharmGKB Accession ID=PA164857070
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs16844489
|overall_frequency_n=7
|overall_frequency_d=128
|overall_frequency=0.0546875
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=8
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}